Zentek (CVE:ZEN) Stock Price Down 8.1% – Time to Sell?

Zentek Ltd. (CVE:ZENGet Free Report) traded down 8.1% during trading on Friday . The stock traded as low as C$0.90 and last traded at C$0.91. 406,043 shares changed hands during mid-day trading, an increase of 309% from the average session volume of 99,199 shares. The stock had previously closed at C$0.99.

Zentek Stock Down 12.1%

The company has a current ratio of 1.00, a quick ratio of 7.59 and a debt-to-equity ratio of 15.41. The firm has a market capitalization of C$93.56 million, a P/E ratio of -10.88 and a beta of 0.34. The company’s fifty day simple moving average is C$0.81 and its 200 day simple moving average is C$0.93.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.

Featured Articles

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.